Magnesium deficiency: Does it have a role to play in cataractogenesis?

Experimental Eye Research

Volumn 101, Issue , 2012, Pages 82-89

  Agarwal, Renu ^a   Iezhitsa, Igor ^a,b   Agarwal, Puneet ^c   Spasov, Alexander ^b  

^a UNIVERSITI TEKNOLOGI MARA   (Malaysia)

^b VOLGOGRAD STATE MEDICAL UNIVERSITY   (Russian Federation)

^c INTERNATIONAL MEDICAL UNIVERSITY   (Malaysia)

Author keywords

Ca 2+ ATPase; Calcium; Cataract; Experimental (animal) models; Magnesium; Na +,K + ATPase; Potassium; Treatment

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ADENOSINE TRIPHOSPHATE; AMILORIDE; AMINOGUANIDINE; ANTIOXIDANT; BUMETANIDE; CALCITONIN; CALCIUM; CATALASE; CHLOROTHIAZIDE; CLAUDIN 16; DISULFIRAM; FUROSEMIDE; GLUCAGON; GLUTATHIONE; N(G) NITROARGININE METHYL ESTER; NITRATE; NITRIC OXIDE; NITRITE; PARATHYROID HORMONE; PLASMA PROTEIN; POTASSIUM; SODIUM; SUPEROXIDE DISMUTASE; TRANSIENT RECEPTOR POTENTIAL CHANNEL M6; TRANSIENT RECEPTOR POTENTIAL CHANNEL M7; VASOPRESSIN;

ABSORPTION; AQUEOUS HUMOR; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CATARACT; CATARACTOGENESIS; CELL MEMBRANE PERMEABILITY; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; DISEASE COURSE; ELECTRON TRANSPORT; ENDOCRINE FUNCTION; GENETIC DISORDER; HENLE LOOP; HOMEOSTASIS; HUMAN; HYPOMAGNESEMIA; LENS; MAGNESIUM BLOOD LEVEL; MAGNESIUM DEFICIENCY; METABOLIC ACIDOSIS; METABOLIC RATE; MITOCHONDRION; NONHUMAN; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; POTASSIUM DEPLETION; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; SENILE CATARACT; ULTRAVIOLET RADIATION; VITREOUS BODY;

ANIMALS; CATARACT; HOMEOSTASIS; HUMANS; LENS, CRYSTALLINE; MAGNESIUM COMPOUNDS; MAGNESIUM DEFICIENCY;

EID: 84864305610     PISSN: 00144835     EISSN: 10960007     Source Type: Journal    
DOI: 10.1016/j.exer.2012.05.008     Document Type: Review

References (111)

1. Alberty R.A. Effect of pH and metal ion concentration on the equilibrium hydrolysis of adenosine triphosphate to adenosine diphosphate. J. Biol. Chem. 1968, 243:253-260.
2. Azuma M., Shearer T.R., Matsumoto T., David L.L., Murachi T. Calpain II in two in vivo models of sugar cataract. Exp. Eye Res. 1990, 51(4):393-401.
3. Baldwin G.F., Bentley P.J. Some observations on the magnesium metabolism of the amphibian lens. Exp. Eye Res. 1980, 31:665-671.
4. Bara M., Guiet-Bara A., Durlach J. Regulation of sodium and potassium pathways by magnesium in cell membranes. Magn. Res. 1993, 6(2):167-177.
5. Barton C.H., Pahl M., Vaziri N.D., Cesario T. Renal magnesium wasting associated with amphotericin B therapy. Am. J. Med. 1984, 77(3):471-474.
6. Baruch A., Greenbaum D., Levy E.T., Nielsen P.A., Gilula N.B., Kumar N.M., Bogyo M. Defining a link between gap junction communication, proteolysis, and cataract formation. J. Biol. Chem. 2001, 276(31):28999-29006.
7. Biswas S., Harris F., Singh J., Phoenix D. Role of calpains in diabetes mellitus-induced cataractogenesis: a mini review. Mol. Cell Biochem. 2004, 261(1-2):151-159.
8. Borchman D., Delamere N.A., Paterson C.A. Ca-ATPase activity in the rabbit and bovine lens. Invest. Ophthalmol. Vis. Sci. 1988, 29(6):982-987.
9. 2+-ATPase activity in the human lens membranes. Curr. Eye Res. 1989, 8:1049-1054.
10. Brunette M.G., Crochet M.E. Fluormetric method for the determination of magnesium in renal tubular fluid. Anal. Biochem. 1975, 65(1-2):79-88.
11. Chubanov V., Gudermann T. Schlingmann KP Essential role for TRPM6 in epithelial magnesium transport and body magnesium homeostasis. Pflugers Arch. 2005, 451(1):228-234.
12. Cole D.E., Quamme G.A. Inherited disorders of renal magnesium handling. J. Am. Soc. Nephrol. 2000, 11(10):1937-1947.
13. Cooper K.E., Tang J.M., Rae J.L., Eisenberg R.S. A cation channel in frog lens epithelia responsive to pressure and calcium. J. Membr. Biol. 1986, 93:259-269.
14. Cowan J.A. Structural and catalytic chemistry of magnesium-dependent enzymes. Biometals 2002, 15(3):225-235.
15. Dai L.J., Ritchie G., Kerstan D., Kang H.S., Cole D.E., Quamme G.A. Magnesium transport in the renal distal convoluted tubule. Physiol. Rev. 2001, 81(1):51-84.
16. de Valk H.W. Magnesium in diabetes mellitus. Neth. J. Med. 1999, 54(4):139-146.
17. Delamere N.A., Dean W.L. Distribution of lens sodium-potassium-adenosine triphosphatase. Invest. Ophthalmol. Vis. Sci. 1993, 34:2159-2163.
18. Devane J., Ryan M.P. Diuretics and magnesium excretion. Magn. Bull. 1981, 3:122-123.
19. Dilsiz N., Olcucu A., Atas M. Determination of calcium, sodium, potassium and magnesium concentrations in human senile cataractous lenses. Cell Biochem. Funct. 2000, 18(4):259-262.
20. Donma O., Yorulmaz E., Pekel H., Suyugül N. Blood and lens lipid peroxidation and antioxidant status in normal individuals, senile and diabetic cataractous patients. Curr. Eye Res. 2002, 25(1):9-16.
21. Duncan G., Webb S.F., Dawson A.P., Bootman M.D., Elliott A.J. Calcium regulation in tissue-cultured human and bovine lens epithelial cells. Invest. Ophthalmol. Vis. Sci. 1993, 34:2835-2842.
22. Dørup, I., 1993. Magnesium and potassium deficiency, its diagnosis, occurrence and treatment in diuretic therapy and its consequences for growth, protein synthesis and growth factors: a Dissertation for Ph.D. degree, Denmark, århus: Institute of Physiology, University of århus, 55 pp.
23. Elin R.J., Hosseini J.M., Gill J.R. Erythrocyte and mononuclear blood cell magnesium concentrations are normal in hypomagnesemic patients with chronic renal magnesium wasting. J. Am. Coll. Nutr. 1994, 13(5):463-466.
24. Emoto M., Nishizawa Y. Diabetes mellitus and magnesium. New Perspectives in Magnesium Research: Nutrition and Health 2007, 197-212. Springer-Verlag, London. Y. Nishizawa, H. Morii, J. Durlach (Eds.).
25. Fodor M., Petrovski G., Moe M.C., Bíró Z., Németh G., Dinya Z., Tornai I., Ujvári T., Berta A., Facskó A. Spectroscopic study of explanted opacified hydrophilic acrylic intraocular lenses. Acta Ophthalmol. 2011, 89(2):e161-e166.
26. Formicki G., Stawarz R. Ultraviolet influence on catalase activity and mineral content in eyeballs of gibel carp (Carassius auratus gibelio). Sci. Total Environ. 2006, 369(1-3):447-450.
27. George G.A., Heaton F.W. Changes in cellular composition during magnesium deficiency. Biochem. J. 1975, 152:609-615.
28. 28 in man. Metabolism 1960, 9:646-659.
29. Greenberg A. Diuretic complications. Am. J. Med. Sci. 2000, 319(1):10-24.
30. Günzel D., Yu A.S. Function and regulation of claudins in the thick ascending limb of Henle. Pflugers Arch. 2009, 458(1):77-88.
31. Haisch L., Almeida J.R., Abreu da Silva P.R., Schlingmann K.P., Konrad M. The role of tight junctions in paracellular ion transport in the renal tubule: lessons learned from a rare inherited tubular disorder. Am. J. Kidney Dis. 2011, 57(2):320-330.
32. Hans C.P., Chaudhary D.P., Bansal D.D. Magnesium deficiency increases oxidative stress in rats. Indian J. Exp. Biol. 2002, 40(11):1275-1279.
33. Heaton F.W. The kidney and magnesium homeostasis. Ann. N.Y. Acad. Sci. 1969, 162(2):775-785.
34. Hightower K.R. Cytotoxic effects of internal calcium on lens physiology. Curr. Eye Res. 1985, 4:453-459.
35. Hightower K.R., Leverenz V., Reddy V.N. Calcium transport in the lens. Invest. Ophthalmol. Vis. Sci. 1980, 19(9):1059-1066.
36. Hightower K.R., David L.L., Shearer T.R. Regional distribution of free calcium in selenite cataract: relation to calpain II. Invest. Ophthalmol. Vis. Sci. 1987, 28(10):1702-1706.
37. Hsu J.M., Rubenstein B., Paleker A.G. Role of magnesium in glutathione metabolism in rat erythrocytes. J. Nutr. 1982, 112:488-496.
38. Iezhitsa I.N. Potassium and magnesium depletions in congestive heart failure - pathophysiology, consequences and replenishment. Clin. Calcium 2005, 15(11):123-133.
39. Iezhitsa I.N., Spasov A.A. Kalii-magnievyi gomeostaz: fiziologiia, patofiziologiia, klinicheskie posledstviia defitsita i osobennosti farmakologicheskoi korrektsii. Usp. Fiziol. Nauk. 2008, 39(1):23-41. (in Russian).
40. Ito Y., Nabekura T., Takeda M., Nakao M., Terao M., Hori R., Tomohiro M. Nitric oxide participates in cataract development in selenite-treated rats. Curr. Eye Res. 2001, 20:446-450.
41. Johansson G. Magnesium metabolism. Scand. J. Urol. Nephr. Suppl. 1979, 51:1-73.
42. Johnson S. The multifaceted and widespread pathology of magnesium deficiency. Med. Hypotheses 2001, 56(2):163-170.
43. Kao C.L., Chou C.K., Tsai D.C., Hsu W.M., Liu J.H., Wang C.S., Lin J.C., Wu C.C., Peng C.H., Chang C.J., Kao C.L., Chiou S.H. Nitric oxide levels in the aqueous humor in cataract patients. J. Cataract. Refract. Surg. 2002, 28:507-512.
44. Keenoy B.M., Moorkens G., Vertommen J., Noe M., Nève J., De Leeuw I. Magnesium status and parameters of the oxidant-antioxidant balance in patients with chronic fatigue: effects of supplementation with magnesium. J. Am. Coll. Nutr. 2000, 19(3):374-382.
45. Kes P., Reiner Z. Symptomatic hypomagnesemia associated with gentamicin therapy. Magn. Trace Elem. 1990, 9(1):54-60.
46. Knoers N.V., de Jong J.C., Meij I.C., Van Den Heuvel L.P., Bindels R.J. Genetic renal disorders with hypomagnesemia and hypocalciuria. J. Nephrol. 2003, 16(2):293-296.
47. Kroll M.H., Elin R.J. Relationships between magnesium and protein concentrations in serum. Clin. Chem. 1985, 31(2):244-246.
48. Kumar B.P., Shivakumar K. Depressed antioxidant defense in rat heart in experimental magnesium deficiency. Implications for the pathogenesis of myocardial lesions. Biol. Trace Elem. Res. 1997, 60(1-2):139-144.
49. Lajer H., Daugaard G. Cisplatin and hypomagnesemia. Cancer Treat. Rev. 1999, 25(1):47-58.
50. Lau K. Magnesium metabolism: normal and abnormal. Fluid, Electrolyte, and Acid-base Disorders 1985, 575-623. Churchill Livingstone, New York. A. Arieff, R.A. DeFronzo (Eds.).
51. 3H-inulin and electrolyte concentrations in Bowman's capsule in rat kidney. Comparison with artificial ultrafiltration. Pflügers Arch. 1975, 354:117-131.
52. Mak I.T., Komarov A.M., Wagner T.L., Stafford R.E., Dickens B.F., Weglicki W.B. Enhanced NO production during Mg deficiency and its role in mediating red blood cell glutathione loss. Am. J. Physiol. 1996, 271(1 Pt 1):C385-C390.
53. Maraini G., Santori M., Carta F. Modifications of adenosine triphosphate and of some enzymatic activities during the development of human senile cataract. Exp. Eye Res. 1967, 6:126-129.
54. Mathys K.C., Cohen K.L., Bagnell C.R. Identification of unknown intraocular material after cataract surgery: evaluation of a potential cause of toxic anterior segment syndrome. J. Cataract. Refract. Surg. 2008, 34(3):465-469.
55. McGahan M.C., Chin B., Bentley P.J. Some observations on the magnesium metabolism of the rabbit lens. Exp. Eye Res. 1983, 36(1):67-73.
56. Mitrović A., Jovanović T. Suplementacija magnezijuma u trudnoći i laktaciji. Srp. Arh. Celok. Lek. 2002, 130(9-10):342-344. (in Serbian).
57. Moiseeva S.L., Iezhitsa I.N., Lediaev M.Y., Spasov A.A. Magnesium homeostasis and blood pressure monitoring in female teenagers with acute and chronic pyelonephritis. Metal Ions in Biology and Medicine 2006, vol. 9:540-545. John Libbey Eurotext, Paris. M.C. Alpoim, P.V. Morais, M.A. Santos, A.J. Cristóvão, J.A. Centeno, P. Collery (Eds.).
58. Moskalev Y.I. Mineral'nyi Obmen 1985, Meditsina, Moskva, (Mineral metabolism. Moscow: Medicine) (in Russian).
59. 2+-ATPase in lenses from normal and hereditary cataract UPL rats. Curr. Eye Res. 2001, 22(6):446-450.
60. Nabekura T., Koizumi Y., Nakao M., Tomohiro M., Inomata M., Ito Y. Delay of cataract development in hereditary cataract UPL rats by disulfiram and aminoguanidine. Exp. Eye Res. 2003, 76:169-174.
61. 2+-ATPase expression and ATP content in lenses of hereditary cataract UPL rats. Toxicology 2004, 197(2):177-183.
62. Nagai N., Ito Y., Inomata M., Shumiya S., Tai H., Hataguchi Y., Nakagawa K. Delay of cataract development in the Shumiya cataract rat by the administration of drinking water containing high concentration of magnesium ion. Biol. Pharm. Bull. 2006, 29(6):1234-1238.
63. Nagai N., Ito Y., Tai H., Hataguchi Y., Nakagawa K. Effects of magnesium content in the feed on cataract development in Shumiya cataract rat. J. Oleo Sci. 2006, 56(1):29-33.
64. Nagai N., Fukuhata T., Ito Y. Effect of magnesium deficiency on intracellular ATP levels in human lens epithelial cells. Biol. Pharm. Bull. 2007, 30(1):6-10.
65. Navarro J.F., Mora-Fernández C. Magnesium in chronic renal failure. New Perspectives in Magnesium Re-search: Nutrition and Health 2007, 303-315. Springer-Verlag, London. Y. Nishizawa, H. Morii, J. Durlach (Eds.).
66. Okazaki M. Magnesium action on the stability of fluorapatite. Magnesium 1988, 7(3):148-153.
67. Okuma Y., Uehara T., Nomura Y. The precise characterization and the crucial mechanism of NO-induced cytotoxicity. Nippon Yakurigaku Zasshi. 1998, 112(3):187-194.
68. Okuno S., Inaba M. Magnesium in Hemodialysis patients. New Perspectives in Magnesium Research: Nutrition and Health 2007, 316-329. Springer-Verlag, London. Y. Nishizawa, H. Morii, J. Durlach (Eds.).
69. Örnek K., Karel F., Büyükbingöl Z. May nitric oxide molecule have a role in the pathogenesis of human cataract?. Exp. Eye Res. 2003, 76(1):23-27.
70. Paik D.C., Dillon J. The nitrite/alpha crystallin reaction: a possible mechanism in lens matrix damage. Exp. Eye Res. 2000, 70:73-80.
71. Paterson C.A. Distribution of sodium and potassium in ox lenses. Exp. Eye Res. 1969, 8:442-446.
72. Paterson C.A., Delamere N.A. ATPases and lens ion balance. Exp. Eye Res. 2004, 78(3):699-703.
73. Purvis J.R., Movahed A. Magnesium disorders and cardiovascular diseases. Clin. Cardiol. 1992, 15(8):556-568.
74. Quamme G.A. Control of magnesium transport in the thick ascending limb. Am. J. Physiol. 1989, 256(2 Pt 2):F197-F210.
75. Quamme G.A., de Rouffignac C. Epithelial magnesium transport and regulation by the kidney. Front. Biosci. 2000, 5:D694-D711.
76. Quamme G.A., Dirks J.H. Magnesium metabolism. Maxwell & Kleeman's Clinical Disorders of Fluid and Electrolyte Metabolism 1994, 373-398. McGraw-Hill Inc. fifth ed. R.G. Narins (Ed.).
77. Quamme G.A., De Rouffignac C. Renal magnesium handling. The Kidney: Physiology and Pathophysiology 2000, Raven Press, New York. third ed. D.W. Seldin, G. Giebisch (Eds.).
78. Retamal M.A., Yin S., Altenberg G.A., Reuss L. Modulation of Cx46 hemichannels by nitric oxide. Am. J. Physiol. Cell Physiol. 2009, 296(6):C1356-C1363.
79. Revúsová V. Poruchy vnútorného prostredia. Osveta Martin 1984, 149-160. (in Slovak). R. Dzúrik (Ed.).
80. Rude R.K. Physiology of magnesium metabolism and the important role of magnesium in potassium deficiency. Am. J. Cardiol. 1989, 63(14):31G-34G.
81. Rude R.K. Magnesium deficiency: a cause of heterogeneous disease in humans. J. Bone Miner. Res. 1998, 13(4):749-758.
82. Schlingmann K.P., Konrad M., Seyberth H.W. Genetics of hereditary disorders of magnesium homeostasis. Pediatr. Nephrol. 2004, 19(1):13-25.
83. Schlingmann K.P., Waldegger S., Konrad M., Chubanov V., Gudermann T. TRPM6 and TRPM7-Gatekeepers of human magnesium metabolism. Biochim. Biophys. Acta 2007, 1772(8):813-821.
84. Seelig M.S. Consequences of magnesium deficiency on the enhancement of stress reactions; preventive and therapeutic implications (a review). J. Am. Coll. Nutr. 1994, 13(5):429-446.
85. Seelig M.S. Interrelationship of magnesium and congestive heart failure. Wien Med. Wochenschr. 2000, 150(15-16):335-341.
86. Shearer T.R., David L.L., Anderson R.S., Azuma M. Review of selenite cataract. Curr. Eye Res. 1992, 11(4):357-369.
87. Shils M.E. Experimental human magnesium depletion. Medicine (Baltimore) 1969, 48(1):61-85.
88. Shumiya S. Establishment of the hereditary cataract rat strain (SCR) and genetic analysis. Lab. Anim. Sci. 1995, 45(6):671-673.
89. Shumiya S., Nagase S. Breeding of hereditary cataract rat. Proc. Jpn. Assoc. Anim. Model Hum. Dis. 1988, 4:30.
90. Sjögren A., Florén C.H., Nilsson A. Magnesium and potassium status in healthy subjects as assessed by analysis of magnesium and potassium in skeletal muscle biopsies and magnesium in mononuclear cells. Magnesium 1987, 6(2):91-99.
91. Spasov A.A. Magnii v Meditsinskoi Praktike (Monografiia) 2000, Volgograd: OOO "Otrok", 272 s. [Magnesium in clinical practice (monograph). Volgograd: Publisher OOO "Otrok", p. 272.] (in Russian).
92. Sreedhara A., Cowan J.A. Structural and catalytic roles for divalent magnesium in nucleic acid biochemistry. Biometals 2002, 15(3):211-223.
93. Stahl E., Buhl R., Schnaudigel O., Steinkamp G., Fries U., Gümbel H., Ohrloff C. Regulation of glutathione level in venous plasma and aqueous humor in cataracta senilis provecta. Der Ophthalmol. Z. Der Deutschen. Ophthalmol. Gesellsch. 1996, 93(1):54-58.
94. Strehler E.E., Zacharias D.A. Role of alternative splicing in generating isoform diversity among plasma membrane calcium pumps. Physiol. Rev. 2001, 81(1):21-50.
95. 2+ fluxes. Exp. Eye Res. 1991, 52:619-627.
96. Tomohiro M., Maruyama Y., Yazawa K., Shinzawa S., Mizuno A. The UPL rat: a new model for hereditary cataracts with two cataract formation types. Exp. Eye Res. 1993, 57(4):507-510.
97. Tomohiro M., Murata S., Yazawa K., Shinzawa S., Maruyama Y., Uga S., Mizuno A., Sakuma S. Lens development and crystallin distribution of the early onset hereditary cataract in the UPL rat. Jpn. J. Ophthalmol. 1996, 40(1):42-52.
98. Tomohiro M., Shinzawa S., Yazawa K., Aida Y., Uga S., Mizuno A., Sakuma S. Late onset hereditary cataracts in UPL rat. J. Toxicol. Pathol. 1996, 9:73-84.
99. Tomohiro M., Sakuma S., Mizuno A. Raman spectroscopic study of late onset hereditary cataracts in the UPL rat. Anim. Eye Res. 1997, 16:95-98.
100. Umeda I.O., Kashiwa Y., Nakata H., Nishigori H. Predominant phosphatase in the ocular lens regulated by physiological concentrations of magnesium and calcium. Life Sci. 2003, 73(9):1161-1173.
101. Varma S.D., Hegde K.R. Susceptibility of the ocular lens to nitric oxide: implications in cataractogenesis. J. Ocul. Pharmacol. Ther. 2007, 23(2):188-195.
102. Vernon W.B. The role of magnesium in nucleic-acid and protein metabolism. Magnesium 1988, 7(5-6):234-248.
103. Vormann J. Magnesium: nutrition and metabolism. Mol. Aspects Med. 2003, 24(1-3):27-37.
104. Wacker W.E., Vallee B.L. Magnesium metabolism. N. Engl. J. Med. 1958, 259(9):431-438. (contd).
105. Wallach S., Bellavia J.V., Reizenstein D.L., Gamponia P.J. Tissue distribution and transport of electrolytes Mg and Ca in hypermagnesemia. Metabolism 1967, 16:451-464.
106. Warnock D.G. Genetic forms of renal potassium and magnesium wasting. Am. J. Med. 2002, 112(3):235-236.
107. Werner L., Hunter B., Stevens S., Chew J.J., Mamalis N. Role of silicon contamination on calcification of hydrophilic acrylic intraocular lenses. Am. J. Ophthalmol. 2006, 141(1):35-43.
108. Wolf F.I., Cittadini A. Chemistry and biochemistry of magnesium. Mol. Aspects Med. 2003, 24(1-3):3-9.
109. 2+-ion catalysis and substrate specificity. Mol. Cell 2006, 22(1):5-13.
110. Yasuda M., Fujimori H., Panhou H. NO depletes cellular ATP contents via inactivation of glyceraldehyde-3-phosphate dehydrogenase in PC12 cells. J. Toxicol. Sci. 1998, 23(5):389-394.
111. Young I.S., Goh E.M., McKillop U.H., Stanford C.F., Nicholls D.P., Trimble E.R. Magnesium status and digoxin toxicity. Br. J. Clin. Pharmacol. 1991, 32(6):717-721.